---
title: "Vineet Laboratories Ltd (VINEETLAB) — Share Price, Financials & Analysis"
symbol: "VINEETLAB"
company: "Vineet Laboratories Ltd"
canonical: "https://tapetide.com/stocks/VINEETLAB"
isin: "INE505Y01010"
nse_symbol: "VINEETLAB"
bse_code: "543298"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 69.01
generated_at: "2026-09-13T18:19:47.322Z"
---

# Vineet Laboratories Ltd (VINEETLAB)

Canonical page: https://tapetide.com/stocks/VINEETLAB

## Company

- **NSE Symbol:** VINEETLAB
- **BSE Code:** 543298
- **ISIN:** INE505Y01010
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2021-06-15
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** vineetlabs.co.in

## About

Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs

## Latest Price

- **Price:** ₹37.02
- **Change:** +1.23 (+3.44%)
- **Open:** ₹37.09
- **Day High:** ₹37.57
- **Day Low:** ₹35.01
- **Previous Close:** ₹35.79
- **Volume:** 71650
- **As Of:** 2026-09-11T10:01:44+00:00

## Key Fundamentals

Observed at 2026-09-11T04:37:06.430700Z.

- **Market Cap:** ₹69.01 Cr
- **Classification:** Microcap
- **P/E (reported):** 63.5
- **P/E (TTM):** 63.83
- **EPS (TTM):** ₹0.58
- **Book Value:** ₹23.75
- **Price to Book:** 1.55
- **Dividend Yield:** 2.79%
- **ROE:** -137.85%
- **ROCE:** -83.36%
- **Debt to Equity:** 0.99
- **Revenue (yearly):** ₹59.4 Cr
- **Net Income:** ₹1.28 Cr
- **EBITDA:** ₹8.48 Cr
- **52-Week High:** ₹43.5
- **52-Week Low:** ₹27.96
- **RSI (14):** 38.79

## Tapetide Score

- **Score:** 45 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 28.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 24.1 | 9% |
| growth | 14.36 | 9% |
| momentum | 78.7 | 12% |
| ownership | 52.97 | 24% |
| quality | 40.89 | 22% |
| valuation | 37.58 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -24.6% over past five years.
- Promoter holding is low: 5.98%
- Company has a low return on equity of -22.7% over last 3 years.
- Promoter holding has decreased over last 3 years: -32.7%
- Working capital days have increased from 26.7 days to 89.0 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 273.83% | 219.44% | -58.2% |
| ebitda margin growth | 0% | -176.74% | 181.07% | 102.99% |
| net income growth | -22.22% | -106.34% | -4% | -9% |
| revenue growth | 20.38% | -22.86% | -35% | -25% |
| roce | — | -762.11% | -736.82% | -1.66% |
| roe | — | — | -43.72% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 37.52 | 43.37 | 32.65 | 37.05 | 23.86 | 18.96 | 18.1 | 14.08 | 7.44 | 17.42 | 15.65 | 18.89 |
| Expenses | 37.26 | 39.2 | 33.29 | 33.63 | 24.65 | 19.27 | 22.23 | 25.12 | 7.13 | 14.24 | 13.17 | 16.4 |
| Operating Profit | 0.26 | 4.17 | -0.64 | 3.42 | -0.79 | -0.31 | -4.13 | -11.04 | 0.31 | 3.18 | 2.48 | 2.49 |
| OPM % | 0.69 | 9.61 | -1.96 | 9.23 | -3.31 | -1.64 | -22.82 | -78.41 | 4.17 | 18.25 | 15.85 | 13.18 |
| Other Income | 0.03 | 0.01 | 0.01 | 0.41 | 0.37 | 0.2 | 0.03 | 1.38 | 0.02 | 0.01 | 0.05 | 0.03 |
| Interest | 0.96 | 1.02 | 1.08 | 1.72 | 1.14 | 0.99 | 0.95 | 0.9 | 0.61 | 2.19 | 1.09 | 0.99 |
| Depreciation | 0.61 | 0.61 | 0.63 | 0.67 | 0.61 | 0.62 | 0.62 | 0.66 | 0.63 | 0.63 | 0.63 | 0.54 |
| Profit before tax | -1.28 | 2.55 | -2.34 | 1.44 | -2.17 | -1.72 | -5.67 | -11.22 | -0.91 | 0.37 | 0.81 | 0.99 |
| Tax % | -2.34 | 4.71 | -11.11 | -34.03 | -1.84 | 6.98 | 0.53 | -6.24 | -4.4 | -8.11 | -3.7 | 27.27 |
| Net Profit | -1.25 | 2.42 | -2.07 | 1.92 | -2.13 | -1.83 | -5.71 | -10.53 | -0.87 | 0.4 | 0.85 | 0.73 |
| EPS in Rs | -0.65 | 1.26 | -1.08 | 1 | -1.11 | -0.95 | -2.97 | -5.48 | -0.45 | 0.21 | 0.44 | 0.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 243.48 | 191.1 | 212.29 | 150.59 | 75 | 59.4 |
| Expenses | 0.01 | 235.33 | 177.94 | 204.63 | 143.39 | 91.28 | 50.91 |
| Operating Profit | -0.01 | 8.15 | 13.16 | 7.66 | 7.2 | -16.28 | 8.49 |
| OPM % | — | 3.35 | 6.89 | 3.61 | 4.78 | -21.71 | 14.29 |
| Other Income | 0 | 0.39 | 0.29 | 0.12 | 0.46 | 1.99 | 0.1 |
| Interest | 0 | 2.67 | 2.09 | 3.38 | 4.78 | 3.98 | 4.89 |
| Depreciation | 0 | 1.81 | 2.02 | 2.37 | 2.52 | 2.5 | 2.41 |
| Profit before tax | -0.01 | 4.06 | 9.34 | 2.03 | 0.36 | -20.77 | 1.29 |
| Tax % | 0 | 56.16 | 28.91 | 38.42 | -183.33 | -2.79 | 13.18 |
| Net Profit | -0.01 | 1.78 | 6.64 | 1.25 | 1.03 | -20.19 | 1.11 |
| EPS in Rs | -0.11 | 0.93 | 3.46 | 0.65 | 0.54 | -10.52 | 0.58 |
| Dividend Payout % | 0 | 0 | 13.89 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.41 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 | 19.21 |
| Reserves | -0.01 | 17.4 | 24 | 24.46 | 25.51 | 5.43 | 26.4 |
| Borrowings | 0 | 12.48 | 26.51 | 31.09 | 44.3 | 40.05 | 45.33 |
| Other Liabilities | 0 | 69.64 | 73.59 | 51.08 | 37.84 | 39.84 | 33.84 |
| Total Liabilities | 0.4 | 108.74 | 133.32 | 115.85 | 116.87 | 94.54 | 124.78 |
| Fixed Assets | 0 | 19.67 | 21.38 | 26.65 | 26.92 | 25.46 | 24.24 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0.12 | 0.14 | 0.13 | 0.18 | 0.21 | 0.19 |
| Other Assets | 0.4 | 88.95 | 111.8 | 89.07 | 89.77 | 68.87 | 100.35 |
| Total Assets | 0.4 | 108.74 | 133.32 | 115.85 | 116.87 | 94.54 | 124.78 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 27.49 | 7.63 | -9.62 | -6.61 | 11.49 | -12.03 |
| Cash from Investing Activity | 0 | -7.81 | -3.68 | -6.69 | -2.22 | -3.18 | -1.11 |
| Cash from Financing Activity | 0 | 18.62 | 11.96 | 0.27 | 8.43 | -8.23 | 29.74 |
| Net Cash Flow | 0 | 38.3 | 15.91 | -16.03 | -0.4 | 0.08 | 16.6 |
| Free Cash Flow | 0 | 27.49 | 7.63 | -17.25 | -9.4 | 10.44 | -13.23 |
| CFO/OP | 0 | 327 | 82 | -87 | -88 | -71 | -144 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 64.03 | 69.14 | 60.45 | 76.59 | 64.48 | 70.05 |
| Inventory Days | — | 73.12 | 109.19 | 97.79 | 158.26 | 259.67 | 606.03 |
| Days Payable | — | 114.08 | 161.2 | 73.9 | 103.37 | 174.65 | 239.52 |
| Cash Conversion Cycle | — | 23.07 | 17.13 | 84.34 | 131.48 | 149.5 | 436.56 |
| Working Capital Days | — | 14.41 | -19.46 | 20.63 | 28.48 | -37.28 | 88.98 |
| ROCE % | — | 34.08 | 23.13 | 8.69 | 6.65 | -27.95 | 8.49 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 38.66% | 37.55% | 37.5% | 37.5% | 36.07% | 35.85% | 35.85% | 29.26% | 15.89% | 12.46% | 5.98% | 5.98% |
| FIIs | 0% | 0.24% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.36% | 0.5% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 58.65% | 58.68% | 59.07% | 59.1% | 60.65% | 59.33% | 58.67% | 66.95% | 78.16% | 82.41% | 88.74% | 88.17% |
| Others | 2.69% | 3.53% | 3.42% | 3.39% | 3.27% | 4.83% | 5.49% | 3.79% | 5.94% | 5.12% | 4.92% | 5.34% |
| No. of Shareholders | 9469 | 9514 | 9638 | 9523 | 10300 | 10058 | 10025 | 9988 | 9682 | 10003 | 9929 | 9901 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 7 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 37.34 | Sell |
| EMA (10) | 37.2 | Sell |
| SMA (20) | 37.68 | Sell |
| EMA (20) | 37.48 | Sell |
| SMA (50) | 37.27 | Sell |
| EMA (50) | 37.12 | Sell |
| SMA (100) | 36.39 | Buy |
| EMA (100) | 36.2 | Buy |
| SMA (200) | 34.71 | Buy |
| EMA (200) | 34.81 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.22 | Neutral |
| MACD (12,26,9) | -0.19 | Sell |
| Stochastic (14,3,3) | 26.94 | Neutral |
| ADX (14) | 23 | Neutral |
| Williams %R (14) | -59.72 | Neutral |
| ATR (14) | 2.05 | High Volatility |
| ROC (12) | -4.56 | Sell |
| Stoch RSI (14) | 47.65 | Neutral |
| UO (7,14,28) | 41.98 | Neutral |

## Filings & Documents

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-29 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7733e9ca-ac3c-469b-a220-0ee124f98233.pdf) |
| 2026-08-25 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efb991b1-d318-4a54-bfd3-1c361c52c4c3.pdf) |
| 2026-02-14 | [Unaudited Standalone Financial Results Along With The Limited Review Report For The Period Ended On December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f709d5-51e4-4183-9edc-07eb475803eb.pdf) |
| 2025-11-08 | [Unaudited Standalone Financial Results Of The Company For The Second Quarter And The Half Year Ended On September 30 2025 Along With The Limited Review Report Submitted By The Statutory Auditors](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53221e66-da26-4e5f-9f69-6d48e0dc99e1.pdf) |
| 2025-07-22 | [Unaudited Standalone Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=104eacb4-90f0-4e92-b82f-1eff01330c11.pdf) |
| 2025-05-12 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Monday May 12 2025 As Required Under Regulation 30 Of SEBI (LODR) 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be9471c9-8d53-4712-a56d-d6afd16c1c85.pdf) |
| 2025-05-12 | [Audited Standalone Financial Results Of The Company For The Fourth Quarter And The Financial Year Ended On 31St March 2025 And The Audited Standalone Financial Statement For The Financial Year Ended On 31St March 2025 Along With Audit Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a76974c-7644-4fe2-b2a9-8f35e42858ef.pdf) |
| 2025-02-12 | [Outcome Of Board Meeting Held On Wednesday November 13 2024 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c03696cd-c3a7-4bad-abcf-f2ad8b8c28ce.pdf) |
| 2024-11-13 | [Outcome Of Board Meeting Held On Wednesday, November 13, 2024 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba1ba1ba-00e1-477f-a401-df9cc7953b04.pdf) |
| 2024-08-13 | [Outcome Of Board Meeting Held On Tuesday, August 13, 2024 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7dd5215a-5639-4ccf-b173-a0f95845cd20.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-25 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday August 25 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da7ee6c6-bf78-4398-a845-65cefa7c86e6.pdf) |
| 2026-08-20 | [Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd29f01e-f151-4743-accc-482594dc89b8.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec9fddf7-32c6-440c-875b-2f90aa0e1ae8.pdf) |
| 2026-07-30 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dec046ad-3d0e-477c-b070-0a85220bf613.pdf) |
| 2026-07-21 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdd60767-6ddf-4f8f-973c-920291c29a56.pdf) |
| 2026-07-21 | [Announcement under Regulation 30 (LODR)-Resignation of Managing Director](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aa6b382-c055-4c44-9709-a8870be5ee08.pdf) |
| 2026-07-16 | [Intimation Of Diferment Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66899fa2-88ef-476b-932f-148f2f50a54d.pdf) |
| 2026-07-11 | [Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65dce5f0-3246-4a8c-8ad8-16e42f25e135.pdf) |
| 2026-05-30 | [Outcome Of Board Meeting Held On May 30 2026 - Deferment Of Consideration Of Audited Standalone Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2d404df-3914-489a-ad53-f080e6123afa.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=373f8f49-39d6-4e3b-9f13-c979e41e7adf.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 21 Apr - Submitted Regulation 74(5) certificate for Q4 and FY2026; no demat/remat requests received. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 21 Apr - Submitted Regulation 74(5) certificate for Q4 and FY2026; no demat/remat requests received.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75725b6c-de63-4d0e-9635-5a11c2073307.pdf) |
| 1d - Submitted Regulation 74(5) certificate for Q4 and FY2026; no demat/remat requests received. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 1d - Submitted Regulation 74(5) certificate for Q4 and FY2026; no demat/remat requests received.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/75725b6c-de63-4d0e-9635-5a11c2073307.pdf) |
| 16 Feb - Copies of Un-audited standalone financial results of the company for the Third quarter and Nine months ended on December 31, 2025 published in following Newspapers … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb - Copies of Un-audited standalone financial results of the company for the Third quarter and Nine months ended on December 31, 2025 published in following Newspapers …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/57edb817-0cdb-45bf-a2cf-4b65558572b4.pdf) |
| 14 Feb - Board approved Q3 and nine-month unaudited results to Dec 31, 2025; limited review unqualified; vendor payments ratified. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, February 14, 2026 As Required Under Regulation 30 Of SEBI (LODR) Regulations, 2015 14 Feb - Board approved Q3 and nine-month unaudited results to Dec 31, 2025; limited review unqualified; vendor payments ratified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3c7a52b-113d-4a98-969c-05719dd0afd8.pdf) |
| 10 Feb - Board meeting Feb 14, 2026 to approve unaudited standalone results for quarter ended Dec 31, 2025. | [Board Meeting Intimation for Considering And Approving The Unaudited Standalone Financial Results Of The Company For The Third Quarter Ended On December 31, 2025 Along With The Limited Review Report 10 Feb - Board meeting Feb 14, 2026 to approve unaudited standalone results for quarter ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/25ec5028-c3db-4ea4-adf7-a9d6bb015d3b.pdf) |
| — | [Closure of Trading Window 30 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4546077-5a16-4aa4-9353-c7ca6b22ebcb.pdf) |
| — | [Unaudited Standalone Financial Results Along With The Limited Review Report For The Period Ended On December 31, 2025 14 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/05f709d5-51e4-4183-9edc-07eb475803eb.pdf) |
| — | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 11 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/137E0CC0_E735_4449_A145_269D23DEB6D8_172921.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e8713f8f-9e67-45e1-9a5e-d802a43b8a09.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/efd84526-a967-42eb-88a9-7b3b84ecf7bd.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e4aed8e-077f-463d-b8ee-3472d5888ff9.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543298/76207543298.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/543298/71989543298.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:19:47.322Z.